Emergence of drug-resistant influenza virus: population dynamical considerations

Science
Roland R Regoes, Sebastian Bonhoeffer

Abstract

Given the considerable challenges to the rapid development of an effective vaccine against influenza, antiviral agents will play an important role as a first-line defense if a new pandemic occurs. The large-scale use of drugs for chemoprophylaxis and treatment will impose strong selection for the evolution of drug-resistant strains. The ensuing transmission of those strains could substantially limit the effectiveness of the drugs as a first-line defense. Summarizing recent data on the rate at which the treatment of influenza infection generates resistance de novo and on the transmission fitness of resistant virus, we discuss possible implications for the epidemiological spread of drug resistance in the context of an established population dynamic model.

References

Jun 1, 1989·The Journal of Infectious Diseases·W J BeanR G Webster
Apr 16, 1998·The Journal of Infectious Diseases·N I StilianakisF G Hayden
Oct 21, 1998·The Journal of Infectious Diseases·L V GubarevaR G Webster
Mar 11, 2000·Lancet·L V GubarevaF G Hayden
Feb 15, 2001·The Journal of Infectious Diseases·L V GubarevaF G Hayden
Jan 10, 2002·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·F G Hayden
Jan 10, 2002·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·N A Roberts
Apr 11, 2003·Vaccine·Arnold S Monto
Jun 26, 2003·The Journal of Infectious Diseases·Kyoko ShiraishiYoshihiro Kawaoka
Dec 4, 2003·Lancet·Karl G NicholsonMaria Zambon
Dec 12, 2003·Nature·Rustom AntiaCarl T Bergstrom
Oct 13, 2004·The Journal of Infectious Diseases·M Louise HerlocherArnold S Monto
Dec 17, 2004·Nature·Christina E MillsMarc Lipsitch
Aug 5, 2005·Science·Ira M LonginiM Elizabeth Halloran
Aug 5, 2005·Nature·Neil M FergusonDonald S Burke
Sep 29, 2005·Antimicrobial Agents and Chemotherapy·Hui-Ling YenElena A Govorkova
Sep 30, 2005·The New England Journal of Medicine·Anne Moscona
Feb 4, 2006·JAMA : the Journal of the American Medical Association·Rick A BrightAlexander I Klimov

❮ Previous
Next ❯

Citations

Nov 28, 2012·Journal of Natural Medicines·Takahiro Haruyama, Kyosuke Nagata
Jul 2, 2009·Bulletin of Mathematical Biology·Zhipeng Qiu, Zhilan Feng
Apr 24, 2013·Journal of Theoretical Biology·Lisa N MurilloAlan S Perelson
Jun 1, 2010·Nature Biotechnology·Richard Y KaoKwok-Yung Yuen
Jul 30, 2009·The Journal of Biological Chemistry·Jean François RossignolM Gabriella Santoro
Jul 19, 2013·Journal of Biological Dynamics·Majid Jaberi-Douraki, Seyed M Moghadas
Mar 16, 2007·Journal of the Royal Society, Interface·Michael GardamHuaiping Zhu
Jul 5, 2007·Journal of the Royal Society, Interface·Florence DébarreRoland R Regoes
Jan 26, 2007·Proceedings. Biological Sciences·Andreas HandelRustom Antia
May 18, 2007·Proceedings. Biological Sciences·Murray E AlexanderPing Yan
Feb 14, 2008·Proceedings. Biological Sciences·Seyed M Moghadas
Oct 1, 2010·Proceedings. Biological Sciences·Elsa Hansen, Troy Day
Feb 6, 2013·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Maciej F BoniH Rogier van Doorn
Jul 17, 2010·Medical Decision Making : an International Journal of the Society for Medical Decision Making·Eunha ShimAlison P Galvani
Jan 22, 2009·BMC Infectious Diseases·Martin EichnerBeatriz Vidondo
Jan 24, 2009·BMC Infectious Diseases·Julien ArinoSeyed M Moghadas
Dec 4, 2009·BMC Medicine·Seyed M MoghadasJianhong Wu
Nov 1, 2008·Virology Journal·Stefan O BrockmannMartin Eichner
Apr 11, 2007·Critical Care : the Official Journal of the Critical Care Forum·Christian Sandrock, Terra Kelly
Dec 12, 2007·PLoS Computational Biology·Andreas HandelRustom Antia
Feb 15, 2013·PLoS Computational Biology·Benjamin M AlthouseLaurent Hébert-Dufresne
Oct 20, 2006·PLoS Medicine·Lori Uscher-PinesRan D Balicer
Jan 27, 2007·PLoS Medicine·Marc LipsitchBruce R Levin
Mar 20, 2008·PloS One·Seyed M MoghadasJianhong Wu
Apr 5, 2013·PloS One·Oscar Patterson-LombaLaurent Hébert-Dufresne
Mar 4, 2014·PloS One·Marek LaskowskiSeyed M Moghadas
Jan 11, 2012·Mathematical Biosciences and Engineering : MBE·Zi SangYun Zou
Mar 5, 2013·Journal of Mathematical Biology·Krisztian Magori, Andrew W Park
Oct 28, 2014·Mathematical Biosciences and Engineering : MBE·Majid Jaberi-Douraki, Seyed M Moghadas
Nov 8, 2014·Evolution, Medicine, and Public Health·Mark M TanakaCarl T Bergstrom

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.